Depending on etiology (genetic predispositions, comorbidities, or endophenotypes, e.g., alcoholism, or ticks), MOR antagonists (rather than agonists) will likely be more appropriate therapeutics (58, 96, 97). This evidence concerns the gene OPRM1 and alcohol drinking.